Development and validation of a medication regimen complexity scoring tool for critically ill patients

Morgan E. Gwynn, Margaret O. Poisson, Jennifer L. Waller, Andrea Sikora Newsome

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose. The purpose of this study was to develop and validate a novel medication regimen complexity-intensive care unit (MRC-ICU) scoring tool in critically ill patients and to correlate MRC with illness severity and patient outcomes. Methods. This study was a single-center, retrospective observational chart review of adults admitted to the medical ICU (MICU) between November 2016 and June 2017. The primary aim was the development and internal validation of the MRC-ICU scoring tool. Secondary aims included external validation of the MRC-ICU and exploration of relationships between medication regimen complexity and patient outcomes. Exclusion criteria included a length of stay of less than 24 hours in the MICU, active transfer, or hospice orders at 24 hours. A total of 130 patient medication regimens were used to test, modify, and validate the MRC-ICU tool. Results. The 39-line item medication regimen complexity scoring tool was validated both internally and externally. Convergent validity was confirmed with total medications (p < 0.0001). Score discriminant validity was confirmed by lack of association with age (p = 0.1039) or sex (p = 0.7829). The MRC-ICU score was significantly associated with ICU length of stay (p = 0.0166), ICU mortality (p = 0.0193), and patient acuity (p < 0.0001). Conclusion. The MRC-ICU scoring tool was validated and found to correlate with length of stay, inpatient mortality, and patient acuity.

Original languageEnglish (US)
Article numberzxy054
Pages (from-to)S34-S40
JournalAmerican Journal of Health-System Pharmacy
Volume76
DOIs
StatePublished - Mar 15 2019

Fingerprint

Critical Illness
Intensive Care Units
Patient Acuity
Length of Stay
Hospices
Mortality
Inpatients

Keywords

  • Critical care
  • Drug therapy
  • Patient safety
  • Pharmacists
  • Pharmacy
  • Scoring tool

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy

Cite this

Development and validation of a medication regimen complexity scoring tool for critically ill patients. / Gwynn, Morgan E.; Poisson, Margaret O.; Waller, Jennifer L.; Newsome, Andrea Sikora.

In: American Journal of Health-System Pharmacy, Vol. 76, zxy054, 15.03.2019, p. S34-S40.

Research output: Contribution to journalArticle

@article{3a43b0c771cd49dd9a9f8ff408c74a4e,
title = "Development and validation of a medication regimen complexity scoring tool for critically ill patients",
abstract = "Purpose. The purpose of this study was to develop and validate a novel medication regimen complexity-intensive care unit (MRC-ICU) scoring tool in critically ill patients and to correlate MRC with illness severity and patient outcomes. Methods. This study was a single-center, retrospective observational chart review of adults admitted to the medical ICU (MICU) between November 2016 and June 2017. The primary aim was the development and internal validation of the MRC-ICU scoring tool. Secondary aims included external validation of the MRC-ICU and exploration of relationships between medication regimen complexity and patient outcomes. Exclusion criteria included a length of stay of less than 24 hours in the MICU, active transfer, or hospice orders at 24 hours. A total of 130 patient medication regimens were used to test, modify, and validate the MRC-ICU tool. Results. The 39-line item medication regimen complexity scoring tool was validated both internally and externally. Convergent validity was confirmed with total medications (p < 0.0001). Score discriminant validity was confirmed by lack of association with age (p = 0.1039) or sex (p = 0.7829). The MRC-ICU score was significantly associated with ICU length of stay (p = 0.0166), ICU mortality (p = 0.0193), and patient acuity (p < 0.0001). Conclusion. The MRC-ICU scoring tool was validated and found to correlate with length of stay, inpatient mortality, and patient acuity.",
keywords = "Critical care, Drug therapy, Patient safety, Pharmacists, Pharmacy, Scoring tool",
author = "Gwynn, {Morgan E.} and Poisson, {Margaret O.} and Waller, {Jennifer L.} and Newsome, {Andrea Sikora}",
year = "2019",
month = "3",
day = "15",
doi = "10.1093/ajhp/zxy054",
language = "English (US)",
volume = "76",
pages = "S34--S40",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",

}

TY - JOUR

T1 - Development and validation of a medication regimen complexity scoring tool for critically ill patients

AU - Gwynn, Morgan E.

AU - Poisson, Margaret O.

AU - Waller, Jennifer L.

AU - Newsome, Andrea Sikora

PY - 2019/3/15

Y1 - 2019/3/15

N2 - Purpose. The purpose of this study was to develop and validate a novel medication regimen complexity-intensive care unit (MRC-ICU) scoring tool in critically ill patients and to correlate MRC with illness severity and patient outcomes. Methods. This study was a single-center, retrospective observational chart review of adults admitted to the medical ICU (MICU) between November 2016 and June 2017. The primary aim was the development and internal validation of the MRC-ICU scoring tool. Secondary aims included external validation of the MRC-ICU and exploration of relationships between medication regimen complexity and patient outcomes. Exclusion criteria included a length of stay of less than 24 hours in the MICU, active transfer, or hospice orders at 24 hours. A total of 130 patient medication regimens were used to test, modify, and validate the MRC-ICU tool. Results. The 39-line item medication regimen complexity scoring tool was validated both internally and externally. Convergent validity was confirmed with total medications (p < 0.0001). Score discriminant validity was confirmed by lack of association with age (p = 0.1039) or sex (p = 0.7829). The MRC-ICU score was significantly associated with ICU length of stay (p = 0.0166), ICU mortality (p = 0.0193), and patient acuity (p < 0.0001). Conclusion. The MRC-ICU scoring tool was validated and found to correlate with length of stay, inpatient mortality, and patient acuity.

AB - Purpose. The purpose of this study was to develop and validate a novel medication regimen complexity-intensive care unit (MRC-ICU) scoring tool in critically ill patients and to correlate MRC with illness severity and patient outcomes. Methods. This study was a single-center, retrospective observational chart review of adults admitted to the medical ICU (MICU) between November 2016 and June 2017. The primary aim was the development and internal validation of the MRC-ICU scoring tool. Secondary aims included external validation of the MRC-ICU and exploration of relationships between medication regimen complexity and patient outcomes. Exclusion criteria included a length of stay of less than 24 hours in the MICU, active transfer, or hospice orders at 24 hours. A total of 130 patient medication regimens were used to test, modify, and validate the MRC-ICU tool. Results. The 39-line item medication regimen complexity scoring tool was validated both internally and externally. Convergent validity was confirmed with total medications (p < 0.0001). Score discriminant validity was confirmed by lack of association with age (p = 0.1039) or sex (p = 0.7829). The MRC-ICU score was significantly associated with ICU length of stay (p = 0.0166), ICU mortality (p = 0.0193), and patient acuity (p < 0.0001). Conclusion. The MRC-ICU scoring tool was validated and found to correlate with length of stay, inpatient mortality, and patient acuity.

KW - Critical care

KW - Drug therapy

KW - Patient safety

KW - Pharmacists

KW - Pharmacy

KW - Scoring tool

UR - http://www.scopus.com/inward/record.url?scp=85068608699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068608699&partnerID=8YFLogxK

U2 - 10.1093/ajhp/zxy054

DO - 10.1093/ajhp/zxy054

M3 - Article

C2 - 31067298

AN - SCOPUS:85068608699

VL - 76

SP - S34-S40

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

M1 - zxy054

ER -